Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Zoetis to Present Data, Tools and Education on the Management of Osteoarthritis (OA) Pain at the 2019 World Small Animal Veterinary Association (WSAVA) Conference
Data on the Role of Anti-NGF (Nerve Growth Factor) in the Management of OA Pain Pathway to Be Highlighted
PARSIPPANY, N.J., July 10, 2019 – Zoetis today announced it will present data and share innovative tools and insights into osteoarthritis (OA) pain control at the 2019 World Small Animal Veterinary Association (WSAVA) Conference in Toronto, Canada, from July 16-19, 2019. The company will highlight a new approach that targets NGF (Nerve Growth Factor) in the pain pathway to enable long-lasting OA pain relief. Several presentations related to research and development in chronic OA pain are scheduled as part of Zoetis’ continued commitment to veterinarians.
“Anti-NGF therapy will undoubtedly play a large role in OA pain management, and it’s important for us to share insights with the veterinary community especially when dogs and cats cannot speak for themselves,” said Joyce Login, DVM, Veterinary Medical Lead, Pain, Oncology and Specialty at Zoetis. “Our data builds on more than 30 years of research and commitment to companion animal pain management. We look forward to presenting at the 2019 WSAVA conference and afterwards making materials available through our new interactive website.”
Highlights of OA-related activities planned by Zoetis at the Conference include:
Data Related to Chronic OA and NGF to be Presented:
• Nerve growth factor, pain and monoclonal antibodies (mAbs) for chronic pain (Dr. Duncan Lascelles; July 17, 8:00 am - 8:50 am EDT, Hall Room 701)• Identifying and measuring osteoarthritis pain in young dogs (Dr. Duncan Lascelles; July 17, 8:55 am - 9:45 am EDT, Hall Room 701• Identifying osteoarthritis pain in cats(Dr. Margaret E. Gruen; July 17, 10:45 am - 11:35 am EDT, Hall Room 701)• Quality of life assessment in cats with chronic osteoarthritis pain (Dr. Margaret E. Gruen, July 17, 1:45 pm - 2:10 pm EDT, Hall Room 701)
“We look forward to discussing the central role of NGF as a driver of osteoarthritis pain at this year’s conference,” said Dr. Duncan Lascelles, BSc, BVSc, PhD, MRCVS, CertVA, DSAS(ST), DECVS, DACVS Professor of Small Animal Surgery and Pain Management, North Carolina State University, Raleigh, NC. “With new approaches and a novel pain pathway on the horizon, we have an opportunity to significantly advance the way we manage OA pain for feline and canines.”
About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit www.zoetis.com.
For further information contact:Colleen White973email@example.com
References1 Slingerland L, Hazewinkel H, Meij B, Picavet P, Voorhout G: Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Vet J 2011: 187: 304-9.2 Johnston SA. Vet Clin North Amer; 1997;27(4)699-723.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.